Adesis partners with pharmaceutical, medical device, and specialty materials companies to develop, scale, and commercialize complex chemistry—from early development through manufacturing in the U.S. and Ireland. As a subsidiary of Universal Display Corporation (Nasdaq OLED), a global leader in organic light-emitting diode (OLED) technologies, Adesis combines scientific depth with the stability and long-term vision of a publicly traded technology innovator.

100,000 sq ft

of US Facilities

17 Acres

of IE Facilities

ISO 9001

Certified

Our Leadership Team

With 30 years of research & knowledge, we serve as a seamless extension of your team, fostering long-term partnerships built on deep collaboration and a shared commitment to your success.

Our Capabilities

Adesis provides chemistry support from early discovery through process development, scale-up, and specialty manufacturing for complex small molecules, peptides and advanced materials.

Our Expertise

Our experts specialize in complex areas like heterocycles, deuteration, and high-purity monomers, leveraging a track record of innovation to solve your most challenging chemistry problems at any scale.

Our Mission

Accelerate our clients’ success through innovative chemistry and solutions from discovery to market.

Our Vision

Innovate for Life.

Our Values

Innovation:
Advance the Line: We are innovators and explorers, pushing boundaries and innovating with quality and speed.

Ownership:
Act with Ownership: We are accountable and personally invested in being the best for our clients and colleagues.

Integrity:
Achieve with Integrity: We are honest, transparent, respectful, and live up to our commitments.

Our History

1991
                         
2005
                   
2016
2017
2018
     
2022
   
2025
1991

CB Research Founded

Founded by Dr. Chuck Beard. Product line includes UV blockers and an extensive catalog of heterocyclic compounds

2005

Adesis Founded

Adesis forms and acquires the assets of CB Research

2016

UDC Acquires Adesis

Strategic partnership in OLED materials

2017

Delaware Expansion

Adesis opens new laboratory facility at Delaware Innovation Space in the DuPont Experimental Station

2018

New Castle Expansion

Adesis further expands New Castle labs to 50,000 sq ft

2022

Major Facility Expansion

Adesis expands at DuPont Experimental Station to >40,000 sq ft, resulting in a total of almost 100,000 sq ft in New Castle and Wilmington, DE

2025

European Expansion

Adesis expands their manufacturing capabilities to include a 17-acre facility in Ireland that includes 3 synthesis plants (SP1–SP3)

Ready to Accelerate Your Success?